{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:42:01Z","timestamp":1793256121905,"version":"4.5.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Sarah Hughes Foundation"},{"DOI":"10.13039\/100001794","name":"Pediatric Brain Tumor Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/neuonc\/noy145","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T23:30:40Z","timestamp":1535067040000},"page":"83-94","source":"Crossref","is-referenced-by-count":200,"title":["Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy"],"prefix":"10.1093","volume":"21","author":[{"given":"Nicole A P","family":"Lieberman","sequence":"first","affiliation":[{"name":"Ben Towne Center for Childhood Cancer Research, Seattle Children\u2019s Research Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kole","family":"DeGolier","sequence":"additional","affiliation":[{"name":"Ben Towne Center for Childhood Cancer Research, Seattle Children\u2019s Research Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M","family":"Kovar","sequence":"additional","affiliation":[{"name":"Ben Towne Center for Childhood Cancer Research, Seattle Children\u2019s Research Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Davis","sequence":"additional","affiliation":[{"name":"Ben Towne Center for Childhood Cancer Research, Seattle Children\u2019s Research Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Hoglund","sequence":"additional","affiliation":[{"name":"Ben Towne Center for Childhood Cancer Research, Seattle Children\u2019s Research Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Stevens","sequence":"additional","affiliation":[{"name":"Center for Clinical and Translational Research, Seattle Children\u2019s Research Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Winter","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Hospital Pathology, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Deutsch","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seattle Children\u2019s Hospital, University of Washington School of Medicine, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott N","family":"Furlan","sequence":"additional","affiliation":[{"name":"Ben Towne Center for Childhood Cancer Research, Seattle Children\u2019s Research Institute, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A","family":"Vitanza","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E S","family":"Leary","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Seattle Children\u2019s Hospital, University of Washington School of Medicine, Fred Hutchinson Cancer Research Center, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney A","family":"Crane","sequence":"additional","affiliation":[{"name":"Ben Towne Center for Childhood Cancer Research, Seattle Children\u2019s Research Institute, Seattle, Washington"},{"name":"Department of Neurological Surgery, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,28]]},"reference":[{"key":"key\n\t\t\t\t2018122123583558700_CIT0001","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/now207","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009\u20132013","volume":"18","author":"Ostrom","year":"2016","journal-title":"Neuro Oncol"},{"issue":"3","key":"key\n\t\t\t\t2018122123583558700_CIT0002","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/14737175.2018.1425617","article-title":"Immunotherapy for brain tumors: understanding early successes and limitations","volume":"18","author":"Lieberman","year":"2018","journal-title":"Expert Rev Neurother"},{"issue":"11","key":"key\n\t\t\t\t2018122123583558700_CIT0003","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1073\/pnas.1101657108","article-title":"Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma","volume":"108","author":"Monje","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"key\n\t\t\t\t2018122123583558700_CIT0004","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","article-title":"Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study","volume":"19","author":"Cooney","year":"2017","journal-title":"Neuro Oncol"},{"issue":"6","key":"key\n\t\t\t\t2018122123583558700_CIT0005","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00401-015-1478-0","article-title":"Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes","volume":"130","author":"Castel","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"5","key":"key\n\t\t\t\t2018122123583558700_CIT0006","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat Genet"},{"issue":"26","key":"key\n\t\t\t\t2018122123583558700_CIT0007","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"key\n\t\t\t\t2018122123583558700_CIT0008","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1084\/jem.20171046","article-title":"Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy","volume":"215","author":"Chheda","year":"2018","journal-title":"J Exp Med"},{"issue":"7","key":"key\n\t\t\t\t2018122123583558700_CIT0009","doi-asserted-by":"crossref","first-page":"e1328340","DOI":"10.1080\/2162402X.2017.1328340","article-title":"K27M-mutant histone-3 as a novel target for glioma immunotherapy","volume":"6","author":"Ochs","year":"2017","journal-title":"Oncoimmunology"},{"issue":"5","key":"key\n\t\t\t\t2018122123583558700_CIT0010","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41591-018-0006-x","article-title":"Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas","volume":"24","author":"Mount","year":"2018","journal-title":"Nat Med"},{"issue":"3","key":"key\n\t\t\t\t2018122123583558700_CIT0011","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00401-014-1274-2","article-title":"CNS macrophages and peripheral myeloid cells in brain tumours","volume":"128","author":"Glass","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"9","key":"key\n\t\t\t\t2018122123583558700_CIT0012","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.4049\/jimmunol.1301966","article-title":"Characterization of distinct immunophenotypes across pediatric brain tumor types","volume":"191","author":"Griesinger","year":"2013","journal-title":"J Immunol"},{"issue":"12","key":"key\n\t\t\t\t2018122123583558700_CIT0013","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1080\/15384047.2016.1250047","article-title":"NKG2D ligand expression in pediatric brain tumors","volume":"17","author":"Haberthur","year":"2016","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"key\n\t\t\t\t2018122123583558700_CIT0014","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11060-017-2737-9","article-title":"Immunophenotyping of pediatric brain tumors: correlating immune infiltrate with histology, mutational load, and survival and assessing clonal T cell response","volume":"137","author":"Plant","year":"2018","journal-title":"J Neurooncol"},{"issue":"1","key":"key\n\t\t\t\t2018122123583558700_CIT0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40478-018-0553-x","article-title":"Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma","volume":"6","author":"Lin","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"18","key":"key\n\t\t\t\t2018122123583558700_CIT0016","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2009.26.7252","article-title":"Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease","volume":"28","author":"Paugh","year":"2010","journal-title":"J Clin Oncol"},{"issue":"2","key":"key\n\t\t\t\t2018122123583558700_CIT0017","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"issue":"6","key":"key\n\t\t\t\t2018122123583558700_CIT0018","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2018122123583558700_CIT0019","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fimmu.2018.00150","article-title":"An uncoupling of canonical phenotypic markers and functional potency of ex vivo-expanded natural killer cells","volume":"9","author":"Lieberman","year":"2018","journal-title":"Front Immunol"},{"issue":"6","key":"key\n\t\t\t\t2018122123583558700_CIT0020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/WCO.0000000000000251","article-title":"Prognostic role of tumour-infiltrating inflammatory cells in brain tumours: literature review","volume":"28","author":"Bie\u0144kowski","year":"2015","journal-title":"Curr Opin Neurol"},{"issue":"8","key":"key\n\t\t\t\t2018122123583558700_CIT0021","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/neuonc\/not082","article-title":"Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma","volume":"15","author":"Lu-Emerson","year":"2013","journal-title":"Neuro Oncol"},{"issue":"3","key":"key\n\t\t\t\t2018122123583558700_CIT0022","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/bjc.2015.212","article-title":"Macrophage polarisation changes within the time between diagnostic biopsy and tumour resection in oral squamous cell carcinomas\u2014an immunohistochemical study","volume":"113","author":"Weber","year":"2015","journal-title":"Br J Cancer"},{"issue":"9","key":"key\n\t\t\t\t2018122123583558700_CIT0023","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/ni.3795","article-title":"Translation is actively regulated during the differentiation of CD8+ effector T cells","volume":"18","author":"Araki","year":"2017","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t2018122123583558700_CIT0024","doi-asserted-by":"crossref","first-page":"vii9","DOI":"10.1093\/neuonc\/nov151","article-title":"Immunosuppressive mechanisms in glioblastoma","volume":"17","author":"Nduom","year":"2015","journal-title":"Neuro Oncol"},{"issue":"4","key":"key\n\t\t\t\t2018122123583558700_CIT0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/neuonc\/nop023","article-title":"Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties","volume":"12","author":"Rodrigues","year":"2010","journal-title":"Neuro Oncol"},{"key":"key\n\t\t\t\t2018122123583558700_CIT0026","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-physiol-022516-034339","article-title":"Macrophage polarization","volume":"79","author":"Murray","year":"2017","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"key\n\t\t\t\t2018122123583558700_CIT0027","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jlb.64.4.419","article-title":"Adoptive immunotherapy of cancer using monocyte-derived macrophages: rationale, current status, and perspectives","volume":"64","author":"Andreesen","year":"1998","journal-title":"J Leukoc Biol"},{"issue":"2","key":"key\n\t\t\t\t2018122123583558700_CIT0028","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/hum.2016.060","article-title":"Genetically engineered macrophages: a potential platform for cancer immunotherapy","volume":"28","author":"Moyes","year":"2017","journal-title":"Hum Gene Ther"},{"key":"key\n\t\t\t\t2018122123583558700_CIT0029","doi-asserted-by":"crossref","first-page":"816460","DOI":"10.1155\/2015\/816460","article-title":"Understanding the mysterious M2 macrophage through activation markers and effector mechanisms","volume":"2015","author":"R\u0151szer","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"1","key":"key\n\t\t\t\t2018122123583558700_CIT0030","doi-asserted-by":"crossref","first-page":"e0191040","DOI":"10.1371\/journal.pone.0191040","article-title":"VEGF may contribute to macrophage recruitment and M2 polarization in the decidua","volume":"13","author":"Wheeler","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"key\n\t\t\t\t2018122123583558700_CIT0031","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ejca.2013.11.014","article-title":"Immunology of cancer stem cells in solid tumours. A review","volume":"50","author":"Maccalli","year":"2014","journal-title":"Eur J Cancer"},{"issue":"5","key":"key\n\t\t\t\t2018122123583558700_CIT0032","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-3083.1991.tb02522.x","article-title":"Inhibition of human natural killer cell activity by platelet-derived growth factor (PDGF). III. Membrane binding studies and differential biological effect of recombinant PDGF isoforms","volume":"33","author":"Gersuk","year":"1991","journal-title":"Scand J Immunol"},{"issue":"26","key":"key\n\t\t\t\t2018122123583558700_CIT0033","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of glioblastoma after chimeric antigen receptor T-cell therapy","volume":"375","author":"Brown","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"key\n\t\t\t\t2018122123583558700_CIT0034","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1038\/s41598-017-05882-0","article-title":"Systematic analysis of gene expression patterns associated with postmortem interval in human tissues","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"key\n\t\t\t\t2018122123583558700_CIT0035","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4049\/jimmunol.171.1.368","article-title":"Vulnerability of human neurons to T cell-mediated cytotoxicity","volume":"171","author":"Giuliani","year":"2003","journal-title":"J Immunol"},{"issue":"1","key":"key\n\t\t\t\t2018122123583558700_CIT0036","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/neuonc\/nop009","article-title":"TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients","volume":"12","author":"Crane","year":"2010","journal-title":"Neuro Oncol"},{"issue":"1","key":"key\n\t\t\t\t2018122123583558700_CIT0037","doi-asserted-by":"crossref","first-page":"e30264","DOI":"10.1371\/journal.pone.0030264","article-title":"Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells","volume":"7","author":"Denman","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"key\n\t\t\t\t2018122123583558700_CIT0038","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-08-3712","article-title":"Expansion of highly cytotoxic human natural killer cells for cancer cell therapy","volume":"69","author":"Fujisaki","year":"2009","journal-title":"Cancer Res"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/21\/1\/83\/27237407\/noy145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T17:45:41Z","timestamp":1571766341000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/21\/1\/83\/5085631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,28]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,8,28]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noy145","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,8,28]]}}}